Browse our wide selection of products for your research needs
We can offer a discount on bulk orders.
Please contact our sales team for further inquiry.
| Product Name | DOX@LNP-PTP-DTPA |
| Catalog Number | LNP-139 |
| Size | 10 mg; 20 mg; 50 mg |
| Alias | Doxorubicin-loaded lipid nanoparticles-targeted transporter protein (PTP)peptide-diethylenetriaminepentaacetic acid complex |
| Appearance | Dispersion |
| Solubility | Good water dispersibility |
| Description | DOX@LNP-PTP peptide-DTPA is a multifunctional drug delivery complex. Lipid nanoparticles (LNP), as the core carrier, have biocompatibility, controllable particle size and surface properties, which can effectively encapsulate doxorubicin to prevent its premature degradation or clearance in the body, while enhancing the stability of the drug. Doxorubicin interferes with the DNA replication and transcription process by intercalating into the DNA double strands of tumor cells, thereby exerting harmful effects on cells. |
| Applications | Drug delivery |
| Storage | -20°C, protected from light |
| Purity | 95%+ |
| Shelf Life | 1 Year |
| Shipping Condition | Low temperature transport |